Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma

NCT00976183 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped toxicities

Conditions

Ovarian Neoplasms

Interventions

DRUG: Vorinostat
DRUG: Vorinostat

Sponsor

Gynecologic Oncology Associates

Collaborators

[object Object]